Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
"Liquid elbows" due to afatinib administration.
Zarogoulidis P, Chinelis P, Athanasiadou A, Porpodis K, Kallianos A, Rapti A, Trakada G, Velentza L, Huang H, Tsiouda T, Hohenforst-Schmidt W. Zarogoulidis P, et al. Among authors: chinelis p. Respir Med Case Rep. 2017 Jun 23;22:64-66. doi: 10.1016/j.rmcr.2017.06.013. eCollection 2017. Respir Med Case Rep. 2017. PMID: 28702338 Free PMC article.
Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases.
Zarogoulidis P, Chinelis P, Athanasiadou A, Tsiouda T, Trakada G, Kallianos A, Veletza L, Hatzibougias D, Mihalopoulou E, Goupou E, Kosmidis C, Sardeli C, Huang H, Hohenforst-Schmidt W. Zarogoulidis P, et al. Among authors: chinelis p. Respir Med Case Rep. 2017 Jul 14;22:101-105. doi: 10.1016/j.rmcr.2017.07.004. eCollection 2017. Respir Med Case Rep. 2017. PMID: 28752057 Free PMC article.
EGFR or PD-L1 decision for first line therapy in a case series of EGFR positive and PD-L1 >50.
Zarogoulidis P, Chinelis P, Efthymiou C, Athanasiadou A, Mpikos V, Papatsibas G, Papadopoulos V, Maragouli E, Huang H, Trakada G, Kallianos A, Veletza L, Hohenforst-Schmidt W. Zarogoulidis P, et al. Among authors: chinelis p. Respir Med Case Rep. 2017 May 30;22:7-10. doi: 10.1016/j.rmcr.2017.05.010. eCollection 2017. Respir Med Case Rep. 2017. PMID: 28761805 Free PMC article.
Re-biopsy after relapse of targeted therapy. T790M after epidermal growth factor mutation, where and why based on a case series.
Zarogoulidis P, Rapti A, Sardeli C, Chinelis P, Athanasiadou A, Paraskevaidou K, Kallianos A, Veletza L, Trakada G, Hohenforst-Schmidt W, Huang H. Zarogoulidis P, et al. Among authors: chinelis p. Respir Med Case Rep. 2017 May 30;21:171-175. doi: 10.1016/j.rmcr.2017.05.013. eCollection 2017. Respir Med Case Rep. 2017. PMID: 28616379 Free PMC article.